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Abstract
Maternal alcohol use during the perinatal period is a major public health issue, the higher ends of which are associated
with foetal alcohol spectrum disorder and a range of adverse health outcomes in the progeny. The underlying molecular
mechanisms remain largely unknown but may include the epigenetic disruption of gene activity during development.
Alcohol directly activates the neurotransmitter dopamine, which plays an essential role in neurodevelopment. To investi-
gate whether antenatal and early postnatal alcohol consumption were associated with differential dopamine receptor DRD4
promoter methylation in infants (n¼844). Data were drawn from the large population based Triple B pregnancy cohort
study, with detailed information on maternal alcohol consumption in each trimester of pregnancy and early postpartum.
DNA was extracted from infant buccal swabs collected at 8-weeks. DRD4 promoter DNA methylation was analysed by
Sequenom MassARRAY.
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Research article
No strong evidence was found for an association between alcohol consumption during pregnancy and infant DRD4 methyla-
tion at 8-weeks postpartum. However, maternal alcohol consumption assessed contemporaneously at 8-weeks postpartum
was associated with increased methylation at 13 of 19 CpG units examined (largest Dþ3.20%, 95%Confidence
Interval:1.66,4.75%, P¼0.0001 at CpG.6). This association was strongest in women who breastfeed, suggesting the possibility of
a direct effect of alcohol exposure via breast milk. The findings of this study could influence public health guidelines around al-
cohol consumption for breastfeeding mothers; however, further research is required to confirm these novel findings.
Key words: alcohol; pregnancy; perinatal; postpartum; dopamine receptor (DRD4); foetal programming; DNA methylation;
epigenetics; breastfeeding
Introduction
Australian prevalence data suggest that alcohol use during
pregnancy is common [1]. A recent National Drug Strategy
Household survey indicated that over 50% of women drank al-
cohol prior to pregnancy awareness, and one in four continued
to drink throughout pregnancy [2]. High maternal alcohol use
during pregnancy is associated with a range of detrimental
short- and long-term effects on the developing foetus, such as
increased risk of birth defects, delayed development and poor
child behaviour [3, 4]. This may occur through foetal program-
ming, where the foetus adapts to its intrauterine environment
to maximize its growth and development in utero, impacting
later health [5]. Alcohol is a known teratogen, and the foetus is
directly exposed to maternal alcohol consumed during preg-
nancy via diffusion across the feto-placental barrier [6]. This
can directly influence foetal development [7]. Accumulating evi-
dence suggests that epigenetic mechanisms, including DNA
methylation, may play a mediating role in foetal programming.
Epigenetics refers to mitotically heritable alterations to cellular
phenotype or gene expression that do not change the underly-
ing DNA sequence [8]. Numerous maternal exposures in preg-
nancy, such as stress, smoking and folate intake, have now
been associated with differential DNA methylation in more
than one study [9–11].
Few studies have investigated the influence of in utero alco-
hol exposure on infant DNA methylation. One epigenome-wide
association study (EWAS) using buccal swab DNA of children
with foetal alcohol spectrum disorder (n¼ 6), identified a num-
ber of genes that were differentially methylated between cases
and controls, particularly genes involved in neurodevelopment
[12]. In terms of more moderate levels of alcohol consumption,
such as a few standard drinks a week which is commonly
observed in the general population, only a few candidate gene
studies have been undertaken. Prenatal alcohol consumption
has been associated with an increase in methylation (3.3%) of
the long interspersed nuclear Element-1 (LINE1) in placenta
(n¼ 380), compared with non-drinkers [13]; however, the sample
size of women reporting prenatal drinking (n¼ 3) was severely
limited. Another study showed that pleiomorphic adenoma
gene-like 1 gene (PLAGL1) in cord blood was differentially
methylated in association with prenatal alcohol use in
Trimester 3 (n¼ 254) [14], although effect sizes were not re-
ported. In a study of 164 cord blood samples, maternal binge
drinking during pregnancy was associated with an 20% in-
crease in methylation at dopamine associated transporter
(DAT1) promoter compared with non-binge drinkers (all other
alcohol groups combined including heavy drinkers) [15]. No
data on the timing of alcohol consumption were available
though, and there was no difference in DAT1 methylation be-
tween non-drinkers and drinkers overall. Genes involved in
dopaminergic signalling, however, do represent good candi-
dates for disruption in response to alcohol exposure.
Motivation to consume alcohol is, in part, thought to be
mediated by reward pathways within the meso-cortico-limbic
system of the mid brain. Dopamine is the primary neurotrans-
mitter within this system and alcohol directly activates dopa-
minergic signalling [16, 17]. Dopaminergic signalling also plays
an important role in mood regulation and neurodevelopment
[18 19]. Disruptions in dopaminergic signalling can result in a
broad range of neuropsychiatric and development conditions,
including depression and schizophrenia [20]. The dopamine re-
ceptor D4 (DRD4) was chosen as a strong candidate gene for in-
vestigation in this study given that it is a key component of
dopamine signalling, responsible for inhibiting adenylate
cyclase during signal transduction [21]. Furthermore, higher
peripheral DRD4 methylation levels have been observed in in
adults with alcohol dependence [22] but no study has yet inves-
tigated whether perinatal alcohol exposure can influence DRD4
methylation in the offspring.
The aim of this study was to examine the association be-
tween maternal alcohol intake during pregnancy and early
postpartum, and infant buccal DRD4 promoter methylation
shortly after birth, taking into account the timing of alcohol ex-
posure and a range of possible confounding perinatal factors.
Methods
Triple B Cohort
Triple B is a longitudinal pregnancy cohort study that recruited
1634 families though public antenatal services associated with
major hospitals in New South Wales and Western Australia,
including specialist drug and alcohol antenatal services.
Mothers and or pregnancies with major medical complications
were excluded. Ethics approval for the study was granted by
the relevant Human Research Ethics Committees, and all
participants provided written informed consent. Participants
responded to questionnaires to gather data on socio-
demographic, health and lifestyle factors across pregnancy and
postpartum. Women self-reported alcohol consumption in each
trimester of pregnancy and during the first 8-weeks postpar-
tum, by completing detailed questionnaires. To address a po-
tential bias in the self-reporting of substance use, a random
selection of participants (n¼ 85) underwent a urine analysis
during the third trimester. Between self-reporting and urine
analysis, the data were 97% in agreement, which indicated the
strong reliability of the reporting.
DRD4 Promoter Region
The 396 bp assay designed using epidesigner.com, covered a re-
gion of the promoter CpG island (chr11:635 510–636 905,
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University of California, Santa Cruz (UCSC) genome build hg38),
previously shown to be differentially methylated [23, 24] (for-
ward primer 50-GGACCCCCTGCCCAGGGTCAGAGG-30; reverse 50-
TGCCAGATACCAGGTGGACTAGGGTG-30). Data were obtainable
for 19 analytical CpG units encompassing 32 CpG sites. DNA
was extracted from 8-week infant buccal samples and 400 ng of
genomic DNA was used for bisulphite conversion [EZ-96 DNA
Methylation-Lightning MagPrep kit (Irvine, USA)]. All samples
were amplified and assayed in triplicate. DNA methylation data
were obtained using the Sequenom MassARRAY EpiTYPER.
Technical replicates passed quality control if they were within
10% of the median sample, and the average methylation was
calculated. CpG units or participants where <85% of methyla-
tion data were obtained after quality control, as well as outliers
(>10% outside 1.5 times the Interquartile Range) were excluded
(Supplementary Table S1).
Statistical Analysis
From 903 extracted infant buccal samples, 844 passed quality
control (technical triplicates within 10% of sample median at
each CpG, and>85% data retained for all CpGs per sample). For
each individual CpG unit, sample number ranged from 743 to
844 (Supplementary Table S1), with 552 samples having com-
plete data for all 19 CpG units. These participants were repre-
sentative of the whole sample, as they did not differ
significantly on the socio-demographic, health and lifestyle
characteristics shown in Table 1.
Univariate analysis was used to investigate the association
between alcohol exposure during pregnancy and mean DRD4
methylation. The association between maternal alcohol con-
sumption at 8-weeks postpartum and mean infant DRD4 methy-
lation at this same time-point was also examined, as were
associations between alcohol exposure and methylation levels
at individual CpG units. When significant associations were
found, multivariate linear regression models were generated
including potential confounding factors, associated with both
alcohol consumption and DRD4 methylation. Batch effects from
different Sequenom Chips were controlled for.
Results
Study Population
The maternal and infant characteristics of the study population
are shown in Table 1. The majority of women consumed alcohol
during pregnancy, predominantly in Trimester 1 prior to preg-
nancy awareness. There was a similar frequency of drinkers at
8-weeks postpartum (61.7%).
Maternal Alcohol Consumption during Pregnancy and
Infant DRD4 Methylation
We first examined whether maternal alcohol use during pregnancy
and early postpartum was associated with differential DRD4
methylation in infants at 8-weeks (Table 2). Mothers who reported
drinking alcohol during Trimester 3 (64.6% of whom also drank in
both Trimesters 1 and 2) had infants with significantly higher
DRD4 methylation levels, both mean levels across the region (Table
2) and at individual 5 of 19 CpG units (Supplementary Table S2).
Postpartum alcohol was also significantly associated with
increased mean DRD4 methylation and at 13 of 19 units, (Table 3
and Supplementary Fig. S1). In the latter case, 5 of these associ-
ations would remain significant even after Bonferroni correction
taking into account the 19 CpG units examined (P< 0.0026). The
largest effect size observed was at CpG.6 (chr11:636 593) (Dþ 1.87,
95%CI:0.21,3.52%, P¼ 0.027 Trimester 3; Dþ 3.20, 95%CI:1.66,4.75%,
P¼ 0.0001 8-week postpartum, Fig. 1).
Given that significant associations were identified with both
maternal alcohol consumption during Trimester 3 and early
postpartum, we sought to disentangle these effects develop-
mentally. It was not possible to isolate the effects of drinking at
Trimester 3, because with the exception of 1 participant, all
mothers who drank in Trimester 3 also drank at 8-weeks post-
partum. Furthermore, only 6% of women drinking in Trimester
3, abstained from drinking at other stages of pregnancy.
However, we could investigate the subpopulation of women
who abstained from drinking alcohol during Trimester 3 but
drank early postpartum (n¼ 161). Indeed, when excluding
Trimester 3 drinkers from the analysis, the strength of associ-
ation between early postpartum alcohol consumption and DRD4
methylation increased in effect size Supplementary Table S3,
CpG.6: 4.87%, P¼ 0.0007.
Multivariate Analysis
As shown in Table 4, women who reported alcohol consump-
tion postpartum were older, more likely to be Australian born,
more highly educated and employed full-time. Infants exposed
to alcohol 8-weeks postpartum were more likely to have had a
longer gestation age and a heavier birthweight. Maternal age
(P¼ 0.11) and education level (P¼ 0.10) also showed moderate
associations with DRD4 methylation, as did tobacco use during
pregnancy (P¼ 0.11). DRD4 promotor methylation also higher in
male infants compared with females (P¼ 0.005). There was no
Table 1. Maternal and infant population characteristics
Population characteristics
Maternal characteristics n Mean 6 SD
Maternal age at child’s birth (years) 821 32.6 6 5.0
Country of birth 844 n(%)
Australia 464 (55.0)
Other 380 (45.0)
Currently living with partner 821 762 (92.8)
Education level 821
Year 12 or under 153 (18.6)
Completed Tafe/tech school 116 (14.1)
Completed university/college 552 (67.3)
Employment 821
Full-time/self-employed 377 (45.9)
Part time/casual 154 (18.8)
Home/student/unemployed 290 (35.3)
Maternal alcohol consumption
At any time during pregnancy 816 561 (68.8)
Trimester 1 816 507 (62.1)
Trimester 2 821 254 (30.9)
Trimester 3 811 254 (31.3)
8-weeks postpartum 814 502 (61.7)
Maternal tobacco use
Any time during pregnancy 812 139 (17.1)
8-weeks postpartum 814 77 (9.5)
Infant characteristics
Sex: male 816 422 (51.7)
Female 394 (48.3)
Mean 6 SD
Gestation age at birth (weeks) 816 39.3 6 1.7
Birthweight (kg) 812 3.5 6 0.5
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significant association between breastfeeding and alcohol con-
sumption early postpartum (P¼ 0.66). We therefore adjusted for
maternal age, education level, plate number (to account for pos-
sible batch effects) and in multivariate models, while also
ensuring that the inclusion of other covariates such as offspring
sex, did not modify the findings. Smoking was included in the
adjusted models given the strong published evidence that it can
influence DNA methylation in the offspring [25]. However, in-
clusion of these covariates had no influence on the findings (i.e.
8-week alcohol consumption, (mean b:þ0.80, SE:0.32, P¼ 0.014;
CpG.6 bþ 2.88, SE 0.79, P< 0.001)).
The Potential Role of Breastfeeding in Alcohol
Transmission
To further investigate our principal finding, that of an associ-
ation between alcohol exposure during the first 8-weeks post-
partum and an increase in infant DRD4 methylation assessed
contemporaneously, we considered the possible role of breast-
feeding. As all participant data were not available at the time of
this study, we focused on the subpopulation of women who re-
ported breastfeeding for the first 8-weeks postpartum (n ranged
from 386–441 for individual CpG units). The maternal and infant
characteristics within this subpopulation were representative of
the whole population (data not shown). The association between
postpartum alcohol consumption and DRD4 methylation was
found to be even stronger in the breastfeeding subpopulation
(i.e. CpG.6:D4.01, 95%CI:1.91,6.11%, P¼ 0.0002; Supplementary
Table S4).
Discussion
The strongest and most consistent finding from our study was
an association between postpartum alcohol consumption and
increased infant DRD4 methylation (at 13 of 19 CpG units) as-
sessed contemporaneously. Furthermore, postpartum alcohol
consumption remained significantly associated with increased
methylation, even after excluding women drinking during preg-
nancy, as well as controlling for other potential confounding
factors. Our results also showed that this association was stron-
gest among women who reported breastfeeding for the first 8-
weeks postpartum, suggesting that transmission of alcohol
through the breast milk may help account for this finding.
Dopaminergic Gene Methylation in Other Studies
DRD4 is enriched in the brain, primarily in the pituitary, amyg-
dala, cerebral cortex and hypothalamus [26]. DRD4 is a key com-
ponent of dopamine signalling and was chosen for this
candidate gene study due to the way alcohol effects dopamine
signalling. It is a D2-like receptor that acts in postsynaptic sig-
nal transduction facilitating the inhibition of adenylate cyclase
[21]. Alcohol does not directly interact with dopamine receptors
such as DRD4; however, when alcohol is consumed, it causes
dopamine release in the brain [27]. This in turn indirectly modu-
lates dopaminergic signal transduction, activating reward path-
ways which can also lead to alcohol dependence [17]. Further,
genetic variants in DRD4 have been associated with attention
deficit hyperactive disorder, alterations in inhibitory behaviour
and other childhood behavioural problems [28].
No previous study has investigated the association between
DRD4 methylation and perinatal alcohol exposure, although
other phenotypes have been explored. DRD4 methylation in per-
ipheral blood has been positively associated with the risk of
schizophrenia in adult males (n¼ 45) but not females [29].
Findings of a study of monozygotic and dizygotic twins
(n¼ 182), suggest that environmental, rather than genetic fac-
tors play a more important role in influencing DNA methylation
of this gene in buccal cells [23]. Another study found increased
blood DRD4 promoter methylation in alcohol dependent adults
versus controls of European American ethnicity (Dþ 0.9% 6 0.1
SEM, P¼ 0.0003, n¼ 249) [22]. This is a similar effect size for
mean methylation observed in our study with postpartum alco-
hol use and infant DNA methylation. Of note, the greatest effect
size observed in our study was with CpG.6, and this lies close to
a specific Protein-1 transcription factor binding site, which is 9
bp upstream [30]. This transcription binding factor is known to
bind to CpG-rich genetic motifs within gene promoter regions,
such as the one investigated within this study. Increased CpG.6
methylation in this region could block the binding of this tran-
scription factor and thus suppress gene transcription [31], high-
lighting a potential functional role of differential methylation at
this site. Although the observed effect sizes are relatively small,
as is the case for most studies in this area, many small changes
in DNA methylation across a network of genes, such as those
within the dopaminergic pathway, may accumulate and result
in potential significant detrimental effects [32].
DNA methylation levels of another gene involved in dopa-
minergic signalling, DAT1, has also been investigated in
Table 2. association between maternal alcohol consumption and infant mean DRD4 promoter methylation
Alcohol consumption DRD4 methylation
n Mean methylation (95%CI) D P
At any stage during pregnancy No 161 36.98 (36.74,37.56) þ0.13 0.704
Yes 375 37.11 (36.75,37.48)
During Trimester 1a No 195 37.09 (36.55,37.62) þ0.05 0.88
Yes 339 37.03 (36.66,37.41)
During Trimester 2a No 367 36.96 (36.59,37.33) þ0.37 0.28
Yes 172 37.32 (36.77,37.88)
During Trimester 3a No 373 36.83 (36.46,37.20) þ0.89 0.0090
Yes 161 37.72 (37.17,38.26)
During the first 8-weeks postpartuma No 202 36.51 (36.02,37.00) þ0.91 0.0049
Yes 334 37.41 (37.02,37.80)
aWomen’s reporting of consumption at that period but not exclusively (i.e. 62% of women consuming alcohol in Trimester 3, also reported consumption in Trimesters
1 and 2).
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association with alcohol exposure. DAT1 is a dopamine trans-
porter that regulates dopamine concentration and the duration
of dopamine neurotransmission within neural synapses by ac-
tively transporting it from the synaptic terminal back into the
cell [33]. Although DAT1 is transcribed from a different genomic
region (chr5), the transporter interacts with DRD4 by making
dopamine available across neuronal synapses for signal trans-
duction. Only one study has investigated an association be-
tween prenatal alcohol use and infant DNA methylation within
the DAT1 promoter in cord blood (n¼ 164) [15]. This study found
that in infants whose mothers binge-drank during pregnancy,
there was an approximate 20% increase in DAT1 promoter
methylation when compared with mothers who were drinkers.
However, no significant results were found when comparing
promoter methylation between drinkers or binge-drinkers and
non-drinkers. A few other studies of DAT1 methylation investi-
gated a direct association with alcohol exposure in adults. A
study of 29 alcohol dependent Caucasian adult males found
that relapsed patients (n¼ 17) had an average 3% higher DAT1
methylation levels in blood compared with the abstinent group
(n¼ 12) [34] but this did not reach significance (P¼ 0.095). In con-
trast, a larger study of 171 alcohol dependant adult Caucasian
men found no significant difference in mean DAT1 methylation
levels in leucocytes, compared with 160 matched healthy con-
trols [35]. However, at one of 23 CpG sites analysed, increased
methylation was observed in the control group (P¼ 0.029, effect
size not stated). Due to its integral part in dopaminergic signal-
ling pathways and these initial findings, DAT1 would be a candi-
date gene for further studies in maternal alcohol use and
differential infant methylation.
Alcohol and Breastfeeding
Our primary finding of an association between maternal alcohol
consumption early postpartum and infant DRD4 methylation in
buccal cells was unexpected and could be explained, at least in
part, by the transmission of alcohol via breast milk. Ethanol,
found in alcoholic drinks, is water soluble and passively diffuses
into breast milk from the blood stream. Within an hour, alcohol
levels in breast milk can reach the same as blood alcohol levels
[36]. The vast majority of studies that have investigated mater-
nal alcohol use and infant outcomes focus solely on the pre-
natal period; however, there is prior evidence to suggest that
breast milk can modify DNA methylation and gene expression
patterns. This could help explain the infant health benefits
from breastfeeding (including lower risk of infections, obesity
and related disorders). For example, lactoferrin in breast
milk may reduce the inflammatory response by inhibiting
NF-kappaB gene expression [37] and binding of lactoferrin to
unmethylated CpGs in bacterial DNA in turn inhibits the immu-
nostimulatory, hence inflammatory effects on human B cells
[38, 39]. The high cholesterol content of breast milk may reduce
endogenous cholesterol synthesis through downregulation of
gene expression, which could explain the reduced cholesterol
levels of adults who were breastfeed in infancy [37].
Our findings highlight the need to consider breastfeeding in
cohort studies of infant DNA methylation patterns generally, as
well as the amount of alcohol neonates are exposed to though
breast milk consumption. This is especially important given
that 62% of women have reported the consummation of alcohol
in the early postnatal period, an important period of brain de-
velopment [40].
Further Research
Although this initial analysis has investigated the associations
between alcohol use at different stages of pregnancy and in the
early postpartum, and infant DRD4 methylation, it is possible
that the dose of exposure during pregnancy is also important,
and this is an avenue for future research in Triple B. Compared
with heavy alcohol use, less is known about low or moderate
maternal drinking pre or post birth. The majority of research
concerns foetal alcohol spectrum disorder with its major
phenotypic alterations as the primary focus. However, direct ef-
fects of low to moderate drinking may be too subtle to detect. A
meta-analysis (n¼ 11 900) of children aged 9 months to 5 years
showed that moderate drinking during pregnancy was associ-
ated with poor child behaviour [41]. However, this meta-
analysis only included 3 studies. Another study (n¼ 4496) found
that low–moderate alcohol during pregnancy (1 standard
drink/week) was not associated with intrauterine growth
Table 3. infant DRD4 methylation according to maternal alcohol
consumption at 8-weeks postpartum
CpG unit Alcohol n Mean
methylation
(95%CI)
Difference (%) P
1 No 304 80.4 (79.8,81.0) þ0.49 0.20
Yes 494 80.9 (80.4,81.3)
2_3 No 303 81.4 (80.8,81.2) þ0.79 0.029
Yes 496 82.2 (81.8,82.6)
4_5 No 311 38.7 (38.3,39.1) þ1.11 <0.0001
Yes 502 39.8 (39.5,40.5)
6 No 279 60.5 (59.3,61.7) þ3.20 0.0001
Yes 441 63.7 (62.7,64.6)
7 No 293 69.6 (68.6,70.6) þ2.00 0.0033
Yes 477 71.6 (70.8,72.5)
8 No 285 71.8 (70.9,72.8) þ1.76 0.0037
Yes 475 73.6 (72.8,74.3)
9 No 294 65.6 (64.5,66.7) þ1.39 0.037
Yes 484 67.0 (66.2,67.7)
12_13_14 No 312 28.2 (27.7,28.8) þ0.98 0.0050
Yes 500 29.2 (28.8,29.6)
15_16_17 No 296 22.0 (21.5,22.5) þ0.61 0.073
Yes 465 22.6 (22.2,23.1)
21_22_23 No 331 18.1 (17.7,18.6) þ0.69 0.028
Yes 498 18.8 (18.4,19.2)
24_25_26 No 312 31.5 (31.1,32.0) þ1.00 0.0011
Yes 501 32.5 (32.2,32.9)
27 No 310 33.4 (33.0,33.8) þ0.77 0.0010
Yes 501 34.2 (33.9,34.5)
28_29 No 311 18.5 (17.9,19.0) þ1.27 0.0003
Yes 498 19.7 (19.3,20.5)
30 No 301 24.2 (23.3,25.1) þ1.04 0.0530
Yes 481 25.3 (24.6,25.9)
32 No 299 1.9 (1.6,2.1) 0.07 0.67
Yes 486 1.8 (1.6,2.0)
34_35 No 312 24.0 (23.6,24.4) þ0.52 0.041
Yes 502 24.5 (24.2,24.8)
36 No 306 13.1 (12.6,13.7) þ0.78 0.0300
Yes 496 13.9 (13.5,14.4)
37_38 No 311 8.3 (8.0,8.6) þ0.06 0.76
Yes 501 8.4 (8.1,8.6)
39 No 312 3.6 (3.4,3.7) þ0.21 0.070
Yes 502 3.8 (3.6,3.9)
Mean No 202 36.5 (36.0,37.0) þ0.91 0.0049
Yes 334 37.4 (37.0,37.8)
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restriction, preterm delivery or low birthweight, all reported
outcomes of heavy pregnancy drinking [42]. Further research
into DNA methylation effects from drinking, especially at low to
moderate amounts of alcohol, and coupled with breastfeeding,
is needed. Further, an important next step within this cohort
will be to determine whether differential DRD4 methylation is
associated with developmental health outcomes in infants.
Strengths and Limitations
The major strength of this study is the large sample size com-
bined with extensive data on the mother–infant dyads. This
included detailed alcohol exposure data and a range of potential
confounding factors. Thus, this study makes an important con-
tribution to the field. Potential limitations to the current ana-
lysis relate to the DRD4 methylation data obtained. Methylation
is known to be dynamic, differing between tissues and cell types
[43], thus the findings presented here are unique to buccal sam-
ples collected from infants at 8-weeks and cannot be
generalized to other tissues or time-points. Even though neur-
onal genes were of specific interest in this study, buccal cells
were used and preferred as a biological sample for their non-
invasive collection method and possible usefulness as a bio-
marker. They are also a very pure cell population derived from
Table 4. population characteristics of mothers and infants, according to alcohol use 8-weeks postpartum
Population characteristics Alcohol consumption 8-weeks postpartum
No (n¼ 312) Yes (n¼ 502) P
Maternal characteristics Mean 6 SD
Maternal age at birth (years) 31.9 6 5.1 33.0 6 4.9 <0.0029
n(%)
Country of birth:
Australia 152 (51.3) 309 (61.6) <0.001
Other 160 (48.7) 193 (38.4)
Currently living with partner 285 (91.4) 472 (94.0) 0.146
Education level
Year 12 or under 70 (22.4) 81 (16.1) 0.015
Completed Tafe/tech school 51 (16.4) 65 (13.0)
Completed university/college 191 (61.2) 356 (70.9)
Employment
Full-time/self-employed 120 (38.5) 254 (50.6) 0.48
Part time/casual 60 (19.2) 93 (18.5)
Home/student/unemployed 132 (42.3) 155 (30.9)
Maternal tobacco use
During pregnancy 52 (16.8) 86 (17.2) 0.88
8-weeks postpartum 25 (8.0) 52 (10.4) 0.27
Infant characteristics
Mean 6 SD
Gestation age at birth (weeks) 39.1 6 1.9 39.5 6 1.5 0.0039
Birthweight (kg) 3.4 6 0.6 3.5 6 0.5 0.040
Figure 1. DRD4 promoter methylation in infants according to maternal alcohol consumption in the first 8-weeks postpartum. (A) Mean promoter methylation (mean ef-
fect 0.91 95%CI:0.28,1.54, P¼0.0049). (B) CpG.6 methylation (mean effect 3.20, 95%CI:1.66,4.75%, P¼0.0001). Whiskers indicate 1.5*IQR, above and below the 75th and
25th percentile, respectively
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embryonic ectoderm, from which neural tissue also arises [44].
Further, recent data have highlighted the utility of buccal-
derived DNA for studies of central nervous system related
phenotypes [23].
As buccal cells would be in direct contact with breast milk,
results may be influenced by maternal DNA contamination
from the milk, resulting in erroneous results. A further limita-
tion to this study is in that DRD4 variable number tandem re-
peats were not accounted for, which have been shown to be
associated with alcohol seeking behaviour [45] and could pos-
sibly influence differences in methylation values [46]. Dose re-
sponse should be investigated in future studies, as well as other
longitudinal time-points, to observe if these effects remain sta-
ble. Another limitation to consider is the small effect sizes
observed, although this is within the range commonly observed
in studies of early-life exposure [32, 47]. Although we do not yet
know how these could translate into biological differences, it is
possible that the accumulation of many small epigenetic
changes during development could be sufficient to result in det-
rimental health outcomes [48]. Further EWASs will enable us to
determine whether groups of genes linked to common signal-
ling pathways are disrupted. Although we considered a range of
covariates in our analysis, it remains possible that other con-
founders, not considered here, have influenced the associ-
ations. Finally, the fact that no buccal samples were collected at
birth made it impossible to fully explore postnatal exposure in
isolation, therefore where possible, these should be collected in
future birth cohort studies.
Conclusion
The Australian Breastfeeding Association suggest that it is safe
to have up to two standard drinks a day after the child is 1
month old, as long as the feed is before the alcohol consump-
tion [49]. This study has found that alcohol exposure postpar-
tum is associated with increased infant methylation. If further
research shows that effects translate into infant health risks, re-
definition of standards may be required, such as altering the al-
cohol free postnatal period and the suggested amount of
alcohol which is consumed. Further studies are needed to repli-
cate our findings, preferably ones that incorporate measure-
ments of genetic variation into modelling of associations, as
well as the timing and dose of exposure pre and postnatally.
Only with robustly replicated findings, can the true reliability of
these associations be ascertained, such as those consistently
replicated studies that found smoking associated changes in
methylation [47, 50 ]. Future studies could focus on the biolo-
gical relevance of this methylation difference and how it is
achieved, whether it equates to changes in gene expression,
whether it remains stable over time and whether these differ-
ences are associated with infant health and development. The
potential for epigenetic variation to mediate the relationship be-
tween maternal exposures and childhood outcomes is an im-
portant area of investigation, with great potential to influence
the health of future generations through the development of
novel interventions.
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